Blueprint Medicines Corp. is a precision therapy company, which engages in the provision of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
649
Frequently Asked Questions
What is Market Cap of Blueprint Medicines Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Blueprint Medicines Corp market cap is $8.36B.
What is the 52-week high for Blueprint Medicines Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Blueprint Medicines Corp 52 week high is $129.65 as of September 28, 2025.
What is the 52-week low for Blueprint Medicines Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Blueprint Medicines Corp 52 week low is $73.04 as of September 28, 2025.
What is Blueprint Medicines Corp stock price today?
Blueprint Medicines Corp stock price today is $129.46.
What was Blueprint Medicines Corp stock price yesterday?
Blueprint Medicines Corp stock price yesterday was $129.28.
What is the PE ratio of Blueprint Medicines Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Blueprint Medicines Corp’s P/E ratio is -52.60.
What is the Price-to-Book ratio of Blueprint Medicines Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Blueprint Medicines Corp P/B ratio is 24.4305.
What is the 50-day moving average of Blueprint Medicines Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Blueprint Medicines Corp 50-day moving average is $128.76.
How many employess does Blueprint Medicines Corp has?
